Acadian Asset Management
VERA icon

Acadian Asset Management’s Vera Therapeutics VERA Stock Holding History

Acadian Asset Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38K Sell
896
-3,063
-77% -$114K ﹤0.01% 1878
2026
Q1 		$159K Hold
3,959
– – ﹤0.01% 1641
2025
Q4 		$200K Buy
+3,959
New +$141K ﹤0.01% 1523
2024
Q4 		– Sell
-2,185
Closed -$96K – 2191
2024
Q3 		$96K Buy
+2,185
New +$82.9K ﹤0.01% 1609

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management's VERA Position: Q2 2026 in Review

Acadian Asset Management reduced its Vera Therapeutics (VERA) stake by 77% in Q2 2026, selling an estimated $114K and leaving 896 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Acadian Asset Management first reported a position in VERA in Q3 2024 and has held it in 4 quarters since. The position peaked at $200K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Acadian Asset Management held 896 shares of Vera Therapeutics worth $38K as of Q2 2026.
  • Acadian Asset Management sold 3,063 Vera Therapeutics shares in Q2 2026, an estimated $114K.
  • Vera Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1878 holding.
  • Acadian Asset Management first reported a position in Vera Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Acadian Asset Management's Vera Therapeutics position peaked at $200K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.